serw-MX  [xml]  
 
    
 DeCS Categories

D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.725 Pyridines .
D03.383.725.203 Dihydropyridines .
D03.383.725.203.510 Nicardipine .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.347 Hormone Antagonists .
D06.347.065 Androgen Antagonists .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.625 Neurotransmitter Agents .
D27.505.519.625.850 Serotonin Agents .
D27.505.519.625.850.850 Serotonin Antagonists .
D27.505.519.914 Sequestering Agents .
D27.505.519.914.500 Chelating Agents .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.399 Hormones, Hormone Substitutes, and Hormone Antagonists .
D27.505.696.399.450 Hormone Antagonists .
D27.505.696.399.450.065 Androgen Antagonists .
D27.505.696.577 Neurotransmitter Agents .
D27.505.696.577.850 Serotonin Agents .
D27.505.696.577.850.850 Serotonin Antagonists .
D27.505.954 Therapeutic Uses .
D27.505.954.502 Hematologic Agents .
D27.505.954.502.780 Platelet Aggregation Inhibitors .
D27.720 Specialty Uses of Chemicals .
D27.720.832 Sequestering Agents .
D27.720.832.500 Chelating Agents .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
/antagonists & inhibitors .
/antagonists and inhibitors .
/antagonists .
/inhibitors .
Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. .
1.00
 
Chelating Agents .
Chelators .
Metal Chelating Agents .
Agents, Chelating .
Agents, Metal Chelating .
Antagonists, Metal .
Chelating Agents, Metal .
Complexons .
Metal Antagonists .
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. .
0.80
 
Nicardipine .
Antagonil .
Cardene .
Cardene I.V. .
Cardene SR .
Dagan .
Flusemide .
Lecibral .
Lincil .
Loxen .
Lucenfal .
Nicardipine Hydrochloride .
Nicardipine LA .
Nicardipino Ratiopharm .
Nicardipino Seid .
Perdipine .
Ridene .
Vasonase .
Y-93 13127 .
Hydrochloride, Nicardipine .
LA, Nicardipine .
Y 93 13127 .
Y93 13127 .
A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. .
0.80
 
Androgen Antagonists .
Anti-Androgen Effect .
Anti-Androgen Effects .
Antiandrogen Effect .
Antiandrogen Effects .
Antagonists, Androgen .
Anti Androgen Effect .
Anti Androgen Effects .
Effect, Anti-Androgen .
Effect, Antiandrogen .
Effects, Anti-Androgen .
Effects, Antiandrogen .
Antiandrogens .
Compounds which inhibit or antagonize the biosynthesis or actions of androgens. .
0.79
 
Protease Inhibitors .
Antiproteases .
Protease Inhibitor .
Antagonists, Protease .
Hydrolase Inhibitors, Peptide .
Inhibitor, Protease .
Inhibitors, Endopeptidase .
Inhibitors, Peptidase .
Inhibitors, Peptide Hydrolase .
Inhibitors, Peptide Peptidohydrolase .
Inhibitors, Protease .
Peptidohydrolase Inhibitors, Peptide .
Endopeptidase Inhibitors .
Peptidase Inhibitors .
Peptide Hydrolase Inhibitors .
Peptide Peptidohydrolase Inhibitors .
Protease Antagonists .
Proteinase Inhibitors .
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). .
0.78
 
Platelet Aggregation Inhibitors .
Antiplatelet Drugs .
Blood Platelet Aggregation Inhibitors .
Blood Platelet Antagonists .
Blood Platelet Antiaggregants .
Platelet Inhibitors .
Agents, Antiplatelet .
Aggregation Inhibitors, Platelet .
Antagonists, Blood Platelet .
Antagonists, Platelet .
Antiaggregants, Blood Platelet .
Drugs, Antiplatelet .
Inhibitors, Platelet .
Inhibitors, Platelet Aggregation .
Antiaggregants, Platelet .
Antiplatelet Agents .
Platelet Antagonists .
Platelet Antiaggregants .
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. .
0.75
 
Serotonin Antagonists .
Antagonists, 5-HT .
Antagonists, 5-Hydroxytryptamine .
Antagonists, Serotonin .
Serotonin Receptor Antagonists .
Serotonin Receptor Blockers .
5 HT Antagonists .
5 Hydroxytryptamine Antagonists .
Agents, Antiserotonergic .
Antagonists, 5 HT .
Antagonists, 5 Hydroxytryptamine .
Antagonists, Serotonin Receptor .
Blockaders, Serotonin .
Blockers, Serotonin Receptor .
Receptor Antagonists, Serotonin .
Receptor Blockers, Serotonin .
Antiserotonergic Agents .
Serotonin Blockaders .
5-Hydroxytryptamine Antagonists .
5-HT Antagonists .
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. .
0.75